Context:
Low levels of adiponectin and T in men have been shown to predict development of the metabolic syndrome, but the effects of T on glucose metabolism are incompletely understood and may be influenced either directly or indirectly through changes in body composition or in levels of adiponectin.
Objective:
The aim of the study was to test whether T exerts its effects on glucose metabolism directly or indirectly.
Design, Setting, and Participants:
In a randomized, double-blind, placebo-controlled, crossover study, 12 healthy young males were studied on four separate occasions. They received GnRH agonist treatment 1 month before 3 of 4 trial days to induce castrate levels of T. On trial days, T gel containing either high or low physiological T dose or placebo was applied to the body. On a fourth trial day, participants constituted their own eugonadal controls.
Intervention:
Each study comprised a 5-hour basal period and a 3-hour hyperinsulinemic euglycemic clamp.
Main Outcome Measures:
We measured the effect of acute T on peripheral glucose disposal, total adiponectin and subforms, and other indices of glucose metabolism.
Results:
Short-term hypogonadism was associated with increased high molecular weight adiponectin levels (P < .03) and increased oxidative glucose disposal (P = .03) but not total glucose disposal (P = .07). Acute T treatment was an independent suppressor of high molecular weight adiponectin levels (P = .04) but did not affect total glucose disposal (P = .17).
Conclusions:
These data show that T can act through putative fast nongenomic pathways to affect adiponectin levels in humans. The early hypogonadal state is characterized by a marked shift in fuel oxidation from lipids toward glucose, which may rely partly on buffering capabilities of adiponectin.
Evaluation of Serum High Molecular Weight Adiponectin in Those Who Do and Do Not Meet American Thoracic Society and Infectious Disease Society of America Criteria for Nontuberculous Mycobacteria Pulmonary Disease
